(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RXEPA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RXEPA

ST13

US500000099412112

Class

42

Filing

99412112

Registration

8187649

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

03/25/2026

Trademark type

Combined

Nice classes

42

Filing date

09/25/2025

Registration date

03/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

03/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

06/25/2020

First use in commerce

06/25/2020

Drawing code

3

Owner type

01

Owner location

Jacksonville, FL, US

Examiner

WU, KRISTEN ZAHNOW

Law office

M50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording “RxEPA.” The letters “Rx” appear in a large stylized form with a capsule or pill design placed diagonally within the letter “R.” The letters “EPA” appear in bold stylized form to the right of “Rx.” A horizontal arrow, composed of a dashed line of rectangular segments, extends from beneath the wording “EPA” and points outward to the right.

Holders and representatives

Holders

V. M. (pessoa física)

Representatives

Vipul Mamtora

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Software as a service (SAAS) services featuring software for automating healthcare electronic prior authorization (ePA) workflows for prescription medications and office proceduresdownloading and reviewing payer-specific formsgathering data and uploading required documentationelectronically submitting prior authorization requests to payersretrieving documents regarding prior authorization determinations and status updatesmanaging information for appeals of prior authorization decisionsfor use by health providerspharmaciespatientspayers

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/12/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/12/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/12/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/12/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/12/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/11/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/11/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/11/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/13/2025

GNRT

NON-FINAL ACTION E-MAILED

12/13/2025

CNRT

NON-FINAL ACTION WRITTEN

12/13/2025

DOCK

ASSIGNED TO EXAMINER

12/11/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/04/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/04/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/25/2025

NWAP

NEW APPLICATION ENTERED

09/25/2025

Continuous trademark protection

Get notified about every new filing that threatens RXEPA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.